Overview

Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population

Status:
Recruiting

Trial end date:
2022-07-31

Target enrollment:

Participant gender:

Summary

This study is being conducted to compare intrathecal morphine using the commercially available intrathecal drug delivery systems (IDDS), and conventional medical management (CMM) in subjects with non-cancer, refractory chronic pain.

Phase:

N/A

Details

Lead Sponsor:

Evolve Restorative Center

Collaborators:

Advanced Infusion Solutions
Celéri Health
Celéri Health, Inc.
Flowonix Medical

Treatments:

Analgesics
Analgesics, Opioid
Morphine
Parasympatholytics